This is a Validated Antibody Database (VAD) review about chimpanzee FOXP3, based on 74 published articles (read how Labome selects the articles), using FOXP3 antibody in all methods. It is aimed to help Labome visitors find the most suited FOXP3 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
FOXP3 synonym: forkhead box protein P3

Invitrogen
rat monoclonal (PCH101)
  • flow cytometry; human; loading ...; fig 1a
Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples (fig 1a). Front Immunol (2019) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; loading ...; fig 2a
Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples (fig 2a). Cancer (2019) ncbi
rat monoclonal (PCH101)
  • immunohistochemistry - frozen section; human; loading ...; fig 2c
Invitrogen FOXP3 antibody (eBiosciences, PCH101) was used in immunohistochemistry - frozen section on human samples (fig 2c). J Infect Dis (2018) ncbi
rat monoclonal (PCH101)
  • flow cytometry; mouse; loading ...; fig 7a
Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on mouse samples (fig 7a). J Clin Invest (2018) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; 1:100; fig 1a
Invitrogen FOXP3 antibody (eBioscience, 12-4776-42) was used in flow cytometry on human samples at 1:100 (fig 1a). Nat Commun (2018) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; loading ...; fig 5a
Invitrogen FOXP3 antibody (ebioscience, PCH101) was used in flow cytometry on human samples (fig 5a). Sci Rep (2017) ncbi
rat monoclonal (PCH101)
  • mass cytometry; human; loading ...; fig 2a
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, Invitrogen FOXP3 antibody (eBiosciences, PCH101) was used in mass cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (PCH101)
  • immunohistochemistry; human; loading ...; fig 8a
In order to investigate the tumor microenvironment in tertiary lymphoid organs of prostate cancer patients, Invitrogen FOXP3 antibody (ebioscience, PCH101) was used in immunohistochemistry on human samples (fig 8a). Front Immunol (2017) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; loading ...; fig 1f
In order to study the oncogenic role of ERK1 in glioma, Invitrogen FOXP3 antibody (ebioscience, 12-4776) was used in flow cytometry on human samples (fig 1f). J Immunol (2017) ncbi
rat monoclonal (PCH101)
  • western blot; human; fig 2g
In order to examine the effect of glucose-6-phosphate transporter mutation on immune cell homeostasis and CD4+ T cell functions, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in western blot on human samples (fig 2g). J Immunol (2017) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; loading ...; fig 6f
In order to investigate origin of tumor-infiltrating T regulatory cells in breast cancer samples, Invitrogen FOXP3 antibody (Thermo Fisher Scientific, 12-4776) was used in flow cytometry on human samples (fig 6f). Cell Res (2017) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; loading ...; fig 2
In order to examine the potential of IL-2 to enhance T regulatory cell therapy, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples (fig 2). Clin Exp Immunol (2017) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; loading ...; fig 3b
In order to characterize the periferal blood lymphocytes phenotype in tacrolimus-treated liver transplanted patients., Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples (fig 3b). Med Princ Pract (2017) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; loading ...; fig 2e
In order to observe that the use of chimeric antigen receptor technology is a clinically applicable refinement of regulatory T cell therapy for organ transplantation, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples (fig 2e). Am J Transplant (2017) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human
  • immunocytochemistry; human; loading ...; fig 4b
Invitrogen FOXP3 antibody (eBiosciences, PCH101) was used in flow cytometry on human samples and in immunocytochemistry on human samples (fig 4b). J Exp Med (2016) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; loading ...
In order to assess how ABCG1 loss in T cells affects atherosclerosis, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples . J Clin Invest (2016) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; loading ...; fig 4b
In order to report that patients with PTEN mutations experience autoimmunity and lymphoid hyperplasia, Invitrogen FOXP3 antibody (NatuTec, PCH101) was used in flow cytometry on human samples (fig 4b). J Allergy Clin Immunol (2017) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; loading ...; fig s1
In order to show that ATG16L1 and NOD2 are required for Bacteroides fragilis-mediated protection from colitis, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples (fig s1). Science (2016) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; loading ...
In order to study the role of T regulatory cells in patients with immune thrombocytopenic purpura, Invitrogen FOXP3 antibody (eBioscience, 12-4776) was used in flow cytometry on human samples . Turk J Haematol (2016) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; 1:20; tbl 2
Invitrogen FOXP3 antibody (eBioscience, 12-4776-42) was used in flow cytometry on human samples at 1:20 (tbl 2). Oncoimmunology (2016) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; fig 3c
In order to assess the impact of neoantigen intratumor heterogeneity on antitumor immunity, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples (fig 3c). Science (2016) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human
Invitrogen FOXP3 antibody (eBioscience, 12-4776) was used in flow cytometry on human samples . Immunity (2016) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; loading ...; fig 1a
In order to examine the relationship between prolactin and T regulatory cells in patients with systemic lupus erythematosus, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples (fig 1a). Medicine (Baltimore) (2016) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; loading ...; fig 8a
Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples (fig 8a). PLoS Pathog (2016) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; loading ...; fig 4d
In order to study the role of human head and neck squamous cell carcinoma-associated semaphorin 4d in myeloid-derived suppressor cells, Invitrogen FOXP3 antibody (eBioscience, 12-4776-42) was used in flow cytometry on human samples (fig 4d). J Immunol (2016) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; fig 4
Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples (fig 4). Haematologica (2016) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human
In order to determine the proportions, phenotype, survival, and apoptotic susceptibility of Tregs in sarcoidosis, Invitrogen FOXP3 antibody (eBiosciences, PCH101) was used in flow cytometry on human samples . Respir Res (2015) ncbi
rat monoclonal (PCH101)
  • immunohistochemistry; human
Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in immunohistochemistry on human samples . World J Urol (2016) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human
In order to investigate the primary inflammatory and regulatory T cell responses induced by BCG vaccination in adults, Invitrogen FOXP3 antibody (eBioscience, clone PCH101) was used in flow cytometry on human samples . Clin Vaccine Immunol (2015) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; loading ...; fig 2b
In order to elucidate Th17 cell polarization, depletion, and restoration in response to HIV infection and antiretroviral therapy, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples (fig 2b). Retrovirology (2015) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; fig st1
Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples (fig st1). Infect Immun (2015) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; 1 ul/test
In order to analyze mucosal pinch biopsies collected predominantly during colonoscopies, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples at 1 ul/test. J Immunol Methods (2015) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; fig 6
In order to describe the phenotype and functional potential of metastatic differentiated thyroid cancer-associated PD-1 positive T cells, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples (fig 6). Cancer Immunol Res (2015) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; fig 2
Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples (fig 2). Cell Res (2015) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; fig 4
Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples (fig 4). Nat Immunol (2015) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; fig 2
Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples (fig 2). Mol Med Rep (2015) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human
Invitrogen FOXP3 antibody (eBiosciences, PCH101) was used in flow cytometry on human samples . J Neuroimmunol (2014) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human
Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples . Hum Immunol (2015) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human
Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples . J Immunol (2015) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human
Invitrogen FOXP3 antibody (e-Bioscience, PCH101) was used in flow cytometry on human samples . Nat Commun (2014) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human
In order to examine the role of TLR7 in HIV-infected CD4 positive T cells, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples . Nat Immunol (2015) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; loading ...; fig 5
In order to study the immune effects of tadalafil in patients with head and neck squamous cell carcinoma., Invitrogen FOXP3 antibody (e-Bioscience, PCH101) was used in flow cytometry on human samples (fig 5). Clin Cancer Res (2015) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human
Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples . J Immunol (2014) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; loading ...; fig 3a
In order to show that latency-associated peptide and glycoprotein A repetitions predominant identify human antigen-specific T regulatory cells, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples (fig 3a). Eur J Immunol (2014) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; fig 1
Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples (fig 1). Immunology (2015) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human
Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples . Blood (2014) ncbi
rat monoclonal (PCH101)
  • immunocytochemistry; human
Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in immunocytochemistry on human samples . Eur J Immunol (2014) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human
  • immunocytochemistry; human
Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples and in immunocytochemistry on human samples . Mol Oncol (2014) ncbi
rat monoclonal (PCH101)
  • immunocytochemistry; human; 1:200
Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in immunocytochemistry on human samples at 1:200. J Crohns Colitis (2014) ncbi
rat monoclonal (PCH101)
  • flow cytometry; African green monkey; 1:20; fig s6
In order to decipher how susequent acute infection is supressed in T cell responses after exposure to subinfectious hepatitis C virus, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on African green monkey samples at 1:20 (fig s6). Nat Med (2013) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; loading ...; fig 2b
In order to test if low immune activation contributes to the viremic slow progressor phenotype, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples (fig 2b). AIDS Res Hum Retroviruses (2013) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; 1:50; fig 1
In order to determine the localization of CD4 positive T cells subsets in the healthy intestine, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples at 1:50 (fig 1). PLoS ONE (2012) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; fig 1
In order to use PI16 to identify a subset of migratory functional memory T regulatory cells, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples (fig 1). Cell Immunol (2012) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; loading ...; fig 3a
In order to test if low-dose interleukin-2 enhances T regulatory cells and suppresses chronic graft-versus-host disease, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples (fig 3a). N Engl J Med (2011) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; loading ...; fig 1a
In order to study the role of T regulatory cells in HIV infection, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples (fig 1a). J Virol (2011) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; fig S5D
In order to examine tumor and nonadjacent normal breast tissue from women with breast cancer, who either had or had not received neoadjuvant chemotherapy before surgery, Invitrogen FOXP3 antibody (eBioscience, 15-4776-42) was used in flow cytometry on human samples (fig S5D). Proc Natl Acad Sci U S A (2012) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; fig s1
In order to identify immunologic correlates of immune reconstitution inflammatory syndrome in HIV patients, Invitrogen FOXP3 antibody (eBioscience, (clone PCH101)) was used in flow cytometry on human samples (fig s1). Blood (2010) ncbi
rat monoclonal (PCH101)
  • immunohistochemistry; human; 1:200; fig 2
Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in immunohistochemistry on human samples at 1:200 (fig 2). J Clin Endocrinol Metab (2010) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; fig 1
In order to study T regulatory cells in inflamed human liver samples, Invitrogen FOXP3 antibody (eBioscience, PCH 101) was used in flow cytometry on human samples (fig 1). J Immunol (2010) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human
In order to identify biomarkers in the first synovial fluid aspirate obtained from children with oligoarticular juvenile idiopathic arthritis, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples . Arthritis Rheum (2010) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human
In order to report that human Tregs promote the generation of myeloid dendritic cells which abrogate post transplant lethality, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples . PLoS Biol (2010) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; fig 4
In order to discuss the role of T regulatory cells in systemic sclerosis and morphoea, Invitrogen FOXP3 antibody (eBiosciences, PCH101) was used in flow cytometry on human samples (fig 4). Br J Dermatol (2010) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; fig 1
In order to examine the therapeutic potential of anti-CD137 mAb in lymphoma, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples (fig 1). Blood (2009) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human
In order to determine the role of CD59 on human CD4+ T cells, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples . J Immunol (2009) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; tbl 1
In order to assess the regulatory function of human CD25+CD4+ T cells at various stages of maturity, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples (tbl 1). Clin Dev Immunol (2008) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; fig 4a
Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples (fig 4a). Blood (2008) ncbi
rat monoclonal (PCH101)
  • western blot; human; 2 ug/ml
Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in western blot on human samples at 2 ug/ml. Cancer Res (2008) ncbi
rat monoclonal (PCH101)
  • flow cytometry; African green monkey
In order to describe the in vitro effects of 5-(4-phenoxybutoxy)psoralen on T cells and its toxicity and pharmacokinetics in rhesus macaques, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on African green monkey samples . Exp Biol Med (Maywood) (2007) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; fig 9A
In order to propose a model in which the gamma chain cytokines IL-2, IL-4, IL-7, and IL-15 maintain the optimal regulatory function of human CD4+ CD25+ T cells in a PI3K-dependent manner, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples (fig 9A). Int Immunol (2007) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human
In order to observe a female patient with a polyautoimmune autoimmune enteropathy syndrome resembling a mild form of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples . Gastroenterology (2007) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human; fig 5
In order to determine the expression of CD39 in mouse and human T cells, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples (fig 5). Blood (2007) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human
In order to determine the presence and functional characteristics of T regulatory cells in colonic lymphoid tissues in patients with ulcerative colitis, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples . Inflamm Bowel Dis (2007) ncbi
rat monoclonal (PCH101)
  • flow cytometry; human
In order to report the expression of chemokine receptors on FOXP3+ T cells, Invitrogen FOXP3 antibody (eBioscience, PCH101) was used in flow cytometry on human samples . J Immunol (2006) ncbi
Articles Reviewed
  1. Lim S, Kim J, Jeon S, Shin M, Kwon J, Kim T, et al. Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients. Front Immunol. 2019;10:496 pubmed publisher
  2. Williams P, Basu S, Garcia Manero G, Hourigan C, Oetjen K, Cortes J, et al. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia. Cancer. 2019;125:1470-1481 pubmed publisher
  3. Patel N, Vukmanovic Stejic M, Suárez Fariñas M, Chambers E, Sandhu D, Fuentes Duculan J, et al. Impact of Zostavax Vaccination on T-Cell Accumulation and Cutaneous Gene Expression in the Skin of Older Humans After Varicella Zoster Virus Antigen-Specific Challenge. J Infect Dis. 2018;218:S88-S98 pubmed publisher
  4. Kawano Y, Zavidij O, Park J, Moschetta M, Kokubun K, Mouhieddine T, et al. Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression. J Clin Invest. 2018;128:2487-2499 pubmed publisher
  5. Hsieh W, Hsu T, Chang Y, Lai M. IL-6 receptor blockade corrects defects of XIAP-deficient regulatory T cells. Nat Commun. 2018;9:463 pubmed publisher
  6. Liaskou E, Jeffery L, Chanouzas D, Soskic B, Seldin M, Harper L, et al. Genetic variation at the CD28 locus and its impact on expansion of pro-inflammatory CD28 negative T cells in healthy individuals. Sci Rep. 2017;7:7652 pubmed publisher
  7. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed publisher
  8. Garcia Hernandez M, Uribe Uribe N, Espinosa González R, Kast W, Khader S, Rangel Moreno J. A Unique Cellular and Molecular Microenvironment Is Present in Tertiary Lymphoid Organs of Patients with Spontaneous Prostate Cancer Regression. Front Immunol. 2017;8:563 pubmed publisher
  9. Ventura E, Weller M, Burghardt I. Cutting Edge: ERK1 Mediates the Autocrine Positive Feedback Loop of TGF-? and Furin in Glioma-Initiating Cells. J Immunol. 2017;198:4569-4574 pubmed publisher
  10. Melis D, Carbone F, Minopoli G, La Rocca C, Perna F, De Rosa V, et al. Cutting Edge: Increased Autoimmunity Risk in Glycogen Storage Disease Type 1b Is Associated with a Reduced Engagement of Glycolysis in T Cells and an Impaired Regulatory T Cell Function. J Immunol. 2017;198:3803-3808 pubmed publisher
  11. Su S, Liao J, Liu J, Huang D, He C, Chen F, et al. Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer. Cell Res. 2017;27:461-482 pubmed publisher
  12. Jeffery H, Jeffery L, Lutz P, Corrigan M, Webb G, Hirschfield G, et al. Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseases. Clin Exp Immunol. 2017;188:394-411 pubmed publisher
  13. Kim J, Kwon C, Joh J, Sinn D, Choi G, Park J, et al. Differences in Peripheral Blood Lymphocytes between Brand-Name and Generic Tacrolimus Used in Stable Liver Transplant Recipients. Med Princ Pract. 2017;26:221-228 pubmed publisher
  14. Boardman D, Philippeos C, Fruhwirth G, Ibrahim M, Hannen R, Cooper D, et al. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection. Am J Transplant. 2017;17:931-943 pubmed publisher
  15. Chopra M, Biehl M, Steinfatt T, Brandl A, Kums J, Amich J, et al. Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion. J Exp Med. 2016;213:1881-900 pubmed publisher
  16. Cheng H, Gaddis D, Wu R, McSkimming C, Haynes L, Taylor A, et al. Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis. J Clin Invest. 2016;126:3236-46 pubmed publisher
  17. Chen H, Händel N, Ngeow J, Muller J, Huhn M, Yang H, et al. Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells. J Allergy Clin Immunol. 2017;139:607-620.e15 pubmed publisher
  18. Chu H, Khosravi A, Kusumawardhani I, Kwon A, Vasconcelos A, Cunha L, et al. Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease. Science. 2016;352:1116-20 pubmed publisher
  19. Akyol Erikci A, Karagoz B, Bilgi O. Regulatory T Cells in Patients with Idiopathic Thrombocytopenic Purpura. Turk J Haematol. 2016;33:153-5 pubmed publisher
  20. Cook A, McDonnell A, Lake R, Nowak A. Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies. Oncoimmunology. 2016;5:e1066062 pubmed
  21. McGranahan N, Furness A, Rosenthal R, Ramskov S, Lyngaa R, Saini S, et al. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. Science. 2016;351:1463-9 pubmed publisher
  22. Procaccini C, Carbone F, Di Silvestre D, Brambilla F, De Rosa V, Galgani M, et al. The Proteomic Landscape of Human Ex Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements. Immunity. 2016;44:406-21 pubmed publisher
  23. Legorreta Haquet M, Chávez Rueda K, Chávez Sánchez L, Cervera Castillo H, Zenteno Galindo E, Barile Fabris L, et al. Function of Treg Cells Decreased in Patients With Systemic Lupus Erythematosus Due To the Effect of Prolactin. Medicine (Baltimore). 2016;95:e2384 pubmed publisher
  24. James E, Gates T, LaFond R, Yamamoto S, Ni C, Mai D, et al. Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome. PLoS Pathog. 2016;12:e1005375 pubmed publisher
  25. Younis R, Han K, Webb T. Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells. J Immunol. 2016;196:1419-29 pubmed publisher
  26. Scottà C, Fanelli G, Hoong S, Romano M, Lamperti E, Sukthankar M, et al. Impact of immunosuppressive drugs on the therapeutic efficacy of ex vivo expanded human regulatory T cells. Haematologica. 2016;101:91-100 pubmed publisher
  27. Broos C, van Nimwegen M, Kleinjan A, Ten Berge B, Muskens F, In t Veen J, et al. Impaired survival of regulatory T cells in pulmonary sarcoidosis. Respir Res. 2015;16:108 pubmed publisher
  28. Horn T, Laus J, Seitz A, Maurer T, Schmid S, Wolf P, et al. The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer. World J Urol. 2016;34:181-7 pubmed publisher
  29. Boer M, Prins C, van Meijgaarden K, van Dissel J, Ottenhoff T, Joosten S. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clin Vaccine Immunol. 2015;22:778-88 pubmed publisher
  30. DaFonseca S, Niessl J, Pouvreau S, Wacleche V, Gosselin A, Cleret Buhot A, et al. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART. Retrovirology. 2015;12:38 pubmed publisher
  31. Obiero J, Shekalaghe S, Hermsen C, Mpina M, Bijker E, Roestenberg M, et al. Impact of malaria preexposure on antiparasite cellular and humoral immune responses after controlled human malaria infection. Infect Immun. 2015;83:2185-96 pubmed publisher
  32. Bowcutt R, Malter L, Chen L, Wolff M, Robertson I, Rifkin D, et al. Isolation and cytokine analysis of lamina propria lymphocytes from mucosal biopsies of the human colon. J Immunol Methods. 2015;421:27-35 pubmed publisher
  33. Severson J, Serracino H, Mateescu V, Raeburn C, McIntyre R, Sams S, et al. PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer. Cancer Immunol Res. 2015;3:620-30 pubmed publisher
  34. Hannani D, Vétizou M, Enot D, Rusakiewicz S, Chaput N, Klatzmann D, et al. Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25. Cell Res. 2015;25:208-24 pubmed publisher
  35. Nguyen L, Pan J, Dinh T, Hadeiba H, O Hara E, Ebtikar A, et al. Role and species-specific expression of colon T cell homing receptor GPR15 in colitis. Nat Immunol. 2015;16:207-213 pubmed publisher
  36. Wu Y, Du Z, Cai Y, Peng W, Zheng G, Zheng G, et al. Effective expansion of forkhead box P3⁺ regulatory T cells via early secreted antigenic target 6 and antigen 85 complex B from Mycobacterium tuberculosis. Mol Med Rep. 2015;11:3134-42 pubmed publisher
  37. Kong L, Wei J, Haider A, Liebelt B, Ling X, Conrad C, et al. Therapeutic targets in subependymoma. J Neuroimmunol. 2014;277:168-75 pubmed publisher
  38. Rueda C, Wells C, Gisslen T, Jobe A, Kallapur S, Chougnet C. Effect of chorioamnionitis on regulatory T cells in moderate/late preterm neonates. Hum Immunol. 2015;76:65-73 pubmed publisher
  39. Huss D, Mehta D, Sharma A, You X, Riester K, Sheridan J, et al. In vivo maintenance of human regulatory T cells during CD25 blockade. J Immunol. 2015;194:84-92 pubmed
  40. Willmann K, Klaver S, DoÄŸu F, Santos Valente E, Garncarz W, Bilic I, et al. Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity. Nat Commun. 2014;5:5360 pubmed publisher
  41. Dominguez Villar M, Gautron A, de Marcken M, Keller M, Hafler D. TLR7 induces anergy in human CD4(+) T cells. Nat Immunol. 2015;16:118-28 pubmed publisher
  42. Weed D, Vella J, Reis I, De La Fuente A, Gomez C, Sargi Z, et al. Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma. Clin Cancer Res. 2015;21:39-48 pubmed publisher
  43. Bacher P, Kniemeyer O, Teutschbein J, Thön M, Vödisch M, Wartenberg D, et al. Identification of immunogenic antigens from Aspergillus fumigatus by direct multiparameter characterization of specific conventional and regulatory CD4+ T cells. J Immunol. 2014;193:3332-43 pubmed publisher
  44. Noyan F, Lee Y, Zimmermann K, Hardtke Wolenski M, Taubert R, Warnecke G, et al. Isolation of human antigen-specific regulatory T cells with high suppressive function. Eur J Immunol. 2014;44:2592-602 pubmed publisher
  45. Kim K, Chung B, Kim B, Cho M, Yang C. The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients. Immunology. 2015;144:68-78 pubmed publisher
  46. Gupta M, Kolli D, Molteni C, Casola A, Garofalo R. Paramyxovirus infection regulates T cell responses by BDCA-1+ and BDCA-3+ myeloid dendritic cells. PLoS ONE. 2014;9:e99227 pubmed publisher
  47. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher
  48. Gautron A, Dominguez Villar M, de Marcken M, Hafler D. Enhanced suppressor function of TIM-3+ FoxP3+ regulatory T cells. Eur J Immunol. 2014;44:2703-2711 pubmed publisher
  49. Grage Griebenow E, Jerg E, Gorys A, Wicklein D, Wesch D, Freitag Wolf S, et al. L1CAM promotes enrichment of immunosuppressive T cells in human pancreatic cancer correlating with malignant progression. Mol Oncol. 2014;8:982-97 pubmed publisher
  50. Naviglio S, Arrigo S, Martelossi S, Villanacci V, Tommasini A, Loganes C, et al. Severe inflammatory bowel disease associated with congenital alteration of transforming growth factor beta signaling. J Crohns Colitis. 2014;8:770-4 pubmed publisher
  51. Park S, Veerapu N, Shin E, Biancotto A, McCoy J, Capone S, et al. Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection. Nat Med. 2013;19:1638-42 pubmed publisher
  52. Shaw J, Hunt P, Critchfield J, McConnell D, Garcia J, Pollard R, et al. Short communication: HIV+ viremic slow progressors maintain low regulatory T cell numbers in rectal mucosa but exhibit high T cell activation. AIDS Res Hum Retroviruses. 2013;29:172-7 pubmed publisher
  53. Wolff M, Leung J, Davenport M, Poles M, Cho I, Loke P. TH17, TH22 and Treg cells are enriched in the healthy human cecum. PLoS ONE. 2012;7:e41373 pubmed publisher
  54. Nicholson I, Mavrangelos C, Bird D, Bresatz Atkins S, Eastaff Leung N, Grose R, et al. PI16 is expressed by a subset of human memory Treg with enhanced migration to CCL17 and CCL20. Cell Immunol. 2012;275:12-8 pubmed publisher
  55. Koreth J, Matsuoka K, Kim H, McDonough S, Bindra B, Alyea E, et al. Interleukin-2 and regulatory T cells in graft-versus-host disease. N Engl J Med. 2011;365:2055-66 pubmed publisher
  56. Shaw J, Hunt P, Critchfield J, McConnell D, Garcia J, Pollard R, et al. Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers. J Virol. 2011;85:11422-34 pubmed publisher
  57. Ruffell B, Au A, Rugo H, Esserman L, Hwang E, Coussens L. Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A. 2012;109:2796-801 pubmed publisher
  58. Antonelli L, Mahnke Y, Hodge J, Porter B, Barber D, DerSimonian R, et al. Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome. Blood. 2010;116:3818-27 pubmed publisher
  59. French J, Weber Z, Fretwell D, Said S, Klopper J, Haugen B. Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer. J Clin Endocrinol Metab. 2010;95:2325-33 pubmed publisher
  60. Oo Y, Weston C, Lalor P, Curbishley S, Withers D, Reynolds G, et al. Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver. J Immunol. 2010;184:2886-98 pubmed publisher
  61. Hunter P, Nistala K, Jina N, Eddaoudi A, Thomson W, Hubank M, et al. Biologic predictors of extension of oligoarticular juvenile idiopathic arthritis as determined from synovial fluid cellular composition and gene expression. Arthritis Rheum. 2010;62:896-907 pubmed publisher
  62. Amarnath S, Costanzo C, Mariotti J, Ullman J, Telford W, Kapoor V, et al. Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1. PLoS Biol. 2010;8:e1000302 pubmed publisher
  63. Antiga E, Quaglino P, Bellandi S, Volpi W, Del Bianco E, Comessatti A, et al. Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea. Br J Dermatol. 2010;162:1056-63 pubmed publisher
  64. Houot R, Goldstein M, Kohrt H, Myklebust J, Alizadeh A, Lin J, et al. Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by Treg depletion. Blood. 2009;114:3431-8 pubmed publisher
  65. Sivasankar B, Longhi M, Gallagher K, Betts G, Morgan B, Godkin A, et al. CD59 blockade enhances antigen-specific CD4+ T cell responses in humans: a new target for cancer immunotherapy?. J Immunol. 2009;182:5203-7 pubmed publisher
  66. Fujimaki W, Takahashi N, Ohnuma K, Nagatsu M, Kurosawa H, Yoshida S, et al. Comparative study of regulatory T cell function of human CD25CD4 T cells from thymocytes, cord blood, and adult peripheral blood. Clin Dev Immunol. 2008;2008:305859 pubmed publisher
  67. Koenen H, Smeets R, Vink P, van Rijssen E, Boots A, Joosten I. Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood. 2008;112:2340-52 pubmed publisher
  68. Ebert L, Tan B, Browning J, Svobodova S, Russell S, Kirkpatrick N, et al. The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells. Cancer Res. 2008;68:3001-9 pubmed publisher
  69. Pereira L, Villinger F, Wulff H, Sankaranarayanan A, Raman G, Ansari A. Pharmacokinetics, toxicity, and functional studies of the selective Kv1.3 channel blocker 5-(4-phenoxybutoxy)psoralen in rhesus macaques. Exp Biol Med (Maywood). 2007;232:1338-54 pubmed
  70. Yates J, Rovis F, Mitchell P, Afzali B, Tsang J, Garin M, et al. The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro. Int Immunol. 2007;19:785-99 pubmed
  71. Zuber J, Viguier M, Lemaitre F, Senée V, Patey N, Elain G, et al. Severe FOXP3+ and naïve T lymphopenia in a non-IPEX form of autoimmune enteropathy combined with an immunodeficiency. Gastroenterology. 2007;132:1694-704 pubmed
  72. Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood. 2007;110:1225-32 pubmed
  73. Yu Q, Saruta M, Avanesyan A, Fleshner P, Banham A, Papadakis K. Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis. Inflamm Bowel Dis. 2007;13:191-9 pubmed
  74. Lim H, Broxmeyer H, Kim C. Regulation of trafficking receptor expression in human forkhead box P3+ regulatory T cells. J Immunol. 2006;177:840-51 pubmed